LICI - Fundamental Analysis: Financial Health & Valuation
Back to ListFundamental Rating: 4.2
| Stock Code | LICI | Market Cap | 5,14,122 Cr. | Current Price | 813 ₹ | High / Low | 980 ₹ |
| Stock P/E | 8.95 | Book Value | 277 ₹ | Dividend Yield | 1.48 % | ROCE | 35.3 % |
| ROE | 38.1 % | Face Value | 10.0 ₹ | DMA 50 | 806 ₹ | DMA 200 | 841 ₹ |
| Chg in FII Hold | 0.11 % | Chg in DII Hold | -0.06 % | PAT Qtr | 23,420 Cr. | PAT Prev Qtr | 12,958 Cr. |
| RSI | 54.7 | MACD | -0.28 | Volume | 1,97,13,378 | Avg Vol 1Wk | 54,79,489 |
| Low price | 722 ₹ | High price | 980 ₹ | PEG Ratio | 0.54 | Debt to equity | 0.00 |
| 52w Index | 35.5 % | Qtr Profit Var | 23.2 % | EPS | 90.8 ₹ | Industry PE | 72.4 |
📊 Core Financials: LIC reports a strong quarterly PAT of ₹23,420 Cr (up from ₹12,958 Cr), reflecting robust growth. ROE at 38.1% and ROCE at 35.3% highlight exceptional efficiency. Debt-to-equity ratio is 0.00, showing a debt-free balance sheet. EPS at ₹90.8 indicates strong earnings power, supported by consistent cash flows.
💹 Valuation Indicators: Stock P/E of 8.95 is significantly lower than the industry average (72.4), suggesting undervaluation. Book value at ₹277 vs CMP ₹813 shows a reasonable P/B multiple. PEG ratio of 0.54 indicates healthy earnings growth relative to price. Intrinsic value appears higher than CMP, offering long-term upside potential.
🏢 Business Model & Advantage: LIC is India’s largest life insurer with a dominant market share, strong brand equity, and extensive distribution network. Its competitive advantage lies in scale, trust, and government backing. The company’s diversified product portfolio and consistent premium inflows ensure long-term sustainability.
📈 Entry Zone & Holding Guidance: The stock trades near DMA 50 (₹806) and DMA 200 (₹841), showing consolidation. RSI at 54.7 indicates neutral momentum. Entry around ₹780–₹820 offers a favorable risk-reward. Long-term holding is recommended given strong fundamentals, undervaluation, and industry tailwinds.
Positive
- ✅ Exceptional ROE (38.1%) and ROCE (35.3%) efficiency
- ✅ Debt-free balance sheet (Debt-to-equity 0.00)
- ✅ Strong quarterly PAT growth (₹12,958 Cr → ₹23,420 Cr)
- ✅ Attractive dividend yield (1.48%)
Limitation
- ⚠️ Stock performance limited by 52-week index at 35.5%
- ⚠️ CMP still below 52-week high (₹980), showing resistance
- ⚠️ Slight decline in DII holding (-0.06%)
Company Negative News
- 📉 Marginal decline in DII holding (-0.06%)
Company Positive News
- 📈 Quarterly profit growth of 23.2% indicates strong operational momentum
- 📈 FII holding increased slightly (+0.11%), showing foreign investor confidence
Industry
- 🌐 Insurance industry PE at 72.4, highlighting sector overvaluation compared to LIC’s low P/E
- 🌐 Long-term demand for life insurance remains strong due to rising financial awareness
Conclusion
🔎 LIC is fundamentally strong with exceptional efficiency, debt-free status, and undervaluation compared to industry peers. Entry near ₹780–₹820 is attractive for long-term investors. Given its dominant market position and strong earnings, LIC is well-suited for long-term holding with potential for significant value appreciation.
You could further explore a peer comparison or a valuation analysis to see how LIC stacks up against competitors and intrinsic value.